Lung Cancer Patients with a Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy

A new study shows that lung cancer patients with a particular type of human leukocyte antigen (HLA) are more likely to benefit from immunotherapy. The study appeared in Nature Cancer. In this study, researchers performed whole-exome sequencing on melanoma and non-small cell lung cancer tumors and blood samples. According to the results, in HLA-B44 non-small … Continue reading Lung Cancer Patients with a Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy